HIV Content

Grant to Create Humanized Mice for HIV Studies

Andy Fell — August 12, 2022 - 2:41pm

Creating a new type of ‘humanized mouse’ that can be infected with HIV is the goal of new project at the Mouse Biology Program of the ��Ƶ, Davis. The work is funded with a grant of nearly $500,000 from the National Institutes of Health.

Pets Help AIDS Survivors Through 2 Pandemics

Amy M Quinton — June 15, 2022 - 9:15am

Survey showed pets helped long-term HIV/AIDS survivors through both the AIDS and COVID-19 pandemics. Older men, especially those with dogs, felt less alone and isolated compared with cat owners.

Rectal Microbes Influence Effectiveness of HIV Vaccine

Andy Fell — December 13, 2019 - 11:03am

Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to researchers at the ��Ƶ, Davis. The work is published Dec. 11 in the journal mSphere.

HIV Vaccine Moves Toward Clinical Trials

Andy Fell — June 15, 2016 - 12:36pm

A vaccine for HIV developed by Oregon Health Sciences University in collaboration with the ��Ƶ National Primate Research Center is now moving towards clinical trials. The vaccine uses another virus, cytomegalovirus or CMV, as a “backbone” to carry small pieces of HIV into the body and arm the immune system.